European Psychiatry - Volume 41 - April 2017

285 / 916

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S238–S302 S281
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
e-Poster Walk: Sexual medicine and mental
health/sleep disorders and stress/eating disorders
EW0513
Dyspareunia after childbirth: Does
psychosocial context play a role?
A. Hajri gueb W. Abdallah Ouali ∗ en Alaya
D. Chelli , F. Nacef
1 Razi hospital, psychiatry A, Manouba, Tunisia
2 Center of maternity and neonatology, gynecology and obstetrics A,
Tunis, Tunisia
∗ Corresponding author.
Introduction Dyspareunia is defined as persistent or recurrent
genital pain that occurs just before, during or after intercourse.
Dyspareunia after childbirth is quite common and have a range of
repercussions to women’s lives, including their sexual functioning.
It could be affected by different risk factors. While role of obstetric
factors including mode of delivery has been largely investigated,
the influence of psychosocial factors remains unclear.
Aims Our purpose was to determine frequency of postpartum
dyspareunia and identify related psychosocial factors.
Methods Thirty women between 2 and 6months postpartum
were recruited in consultation of maternity and neonatology cen-
ter of Tunis. Data were taken from medical file and questionnaire
designed to record psychosocial data and postpartum sexual func-
tion.
Results The mean age of women was 28.74 ± 8.4 years. Dyspare-
unia was reported by 43.33% of women. Dyspareunia was not
associated to professional status. On the other hand, dyspareunia
was significantly associated to fatigue (P = 0.024), lack of familial
support (P = 0.03), conjugal conflicts ( P = 0.01).
Conclusion We have found an association between dyspareunia
after childbirth and several psychosocial factors, pointing out the
influence of social and psychological aspects in the sexual function
in women. Thus, management of sexual disorders should take in
consideration psychological dimension and involve an appropriate
psychological care.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW0514
Self-image and risk of suicide in
eating disorders
A. Birgegård ∗, M. Andersen
Karolinska Institute, Department of Clinical Neuroscience, Stockholm,
Sweden
∗ Corresponding author.
Introduction Suicide risk is increased in eating disorders (ED),
and detection is key to prevention. Self-image as operationalized
in the structural analysis of social behavior (SASB) model has been
shown to be associated with symptoms, treatment dropout, and
outcome. SASB is a circumplex organizing self-directed behaviors
along affiliation (love vs. hate) and autonomy (set free vs. control)
dimensions. In a recent study, SASB related to health care-detected
suicide attempts in ED. Methodology in that study ensured high
specificity but risked lower sensitivity in suicide variables, andwith
such a high-threat outcome, research is needed on additional vari-
ables related to risk.
Objectives and aims We aimed to study associations between
SASB self-image and clinician- and self-rated suicidality at presen-
tation and predicted over 12months in ED patients.
Methods Adult patients (n = 551) from a Swedish clinical
database included 19% anorexia, 32% bulimia, 7% binge ED, and 42%
other ED. We ran separate regression models for these diagnostic
groups using SASB questionnaire data, also controlling for general
psychiatric and ED symptoms, and in longitudinal models including
baseline of each outcome.
Results SASB alone was associated with suicidality at presenta-
tion (9–67% variance explained) and predictively over 12months
(7–29%), and in the majority of models explained additional vari-
ance beyond baseline and clinical variables. Both affiliation and
autonomy related to dependent variables in diagnosis-specific pat-
terns.
Conclusions The findings have implications for both theory and
detection tools for suicide risk, as well as suggesting intervention
targets to mitigate risk in treatment based on the well-validated
SASB theory.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW0515
Rosa Damascena improved sexual
dysfunction in males under
methadone treatment – results from a
double-blind, randomized,
placebo-controlled clinical trial
V. Farnia , F. Tatari , M. Alikhani , J. Shakeri , M. Taghizadeh ,
V.T. Ngo , D. Sadeghi Bahmani , E. Holsboer-Trachsler ,
S. Brand ∗
1 Kermanshah University of Medical Sciences, Substance Abuse
Prevention Research Center, Psychiatry Department, Kermanshah,
Iran
2 Kashan University of Medical Sciences, Research Center for
Biochemistry and Nutrition in Metabolic Diseases, Kashan, Iran
3 Psychiatric Clinics of the University of Basel, Center for Affective,
Stress and Sleep Disorders, Basel, Switzerland
4 Psychiatric University Hospital, Center for Affective, Stress and Sleep
Disorders, Basel, Switzerland
∗ Corresponding author.
Introduction Patients with severe opioid dependency might be
treated withmethadone, a pure -opioid-receptor, with promising
results. Though, as for opioids, side effects are high, and among
those, sexual dysfunction is among themost disturbing side effects.
Aims Investigating the influence of Rosa Damascena oil to
improve sexual dysfunction among male methadone users.
Methods A total of 60 male patients (mean age: 30 years) with
diagnosed opioid dependence and currently under treatment of
methadone were randomly assigned either to the verum (Rosa
Damascenca oil drops) or placebo condition. At baseline, and four
and eight weeks later, patients completed self-rating question-
naires covering sexual dysfunction and happiness.
Results Over time sexual dysfunction decreased and happiness
increased in the verum, but not in the placebo condition.
Conclusions Results from this double blind, randomized, and
placebo-controlled clinical trial showed that Rosa Damascena oil
improved sexual dysfunction and happiness among male opioid
addicts while under substitution treatment with methadone.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.